The size-reduced Eudragit® RS microparticles prepared by solvent evaporation method - monitoring the effect of selected variables on tested parameters

Vasileiou, K.; Vysloužil, J.; Pavelková, M.; Vysloužil, J.; Kubová, K.řina.

Ceska a Slovenska farmacie casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti 66(6): 274-280

2018


ISSN/ISBN: 1210-7816
PMID: 29623709
Document Number: 695773
Size-reduced microparticles were successfully obtained by solvent evaporation method. Different parameters were applied in each sample and their influence on microparticles was evaluated. As a model drug the insoluble ibuprofen was selected for the encapsulation process with Eudragit® RS. The obtained microparticles were inspected by optical microscopy and scanning electron microscopy. The effect of aqueous phase volume (600, 400, 200 ml) and the concentration of polyvinyl alcohol (PVA; 1.0% and 0.1%) were studied. It was evaluated how those variations and also size can affect microparticle characteristics such as encapsulation efficiency, drug loading, burst effect and microparticle morphology. It was observed that the sample prepared with 600 ml aqueous phase and 1% concentration of polyvinyl alcohol gave the most favorable results.Key words: microparticles solvent evaporation sustained drug release Eudragit RS®.

Document emailed within 1 workday
Secure & encrypted payments